Published in CA Cancer J Clin on April 27, 1999
Low-Fat Fish Oil Diet for Prostate Cancer Prevention | NCT00798876
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck | NCT00011778
CAR-T Cell Immunotherapy for Advanced Lung Cancer | NCT03330834
Effect of computer support on younger women with breast cancer. J Gen Intern Med (2001) 5.12
Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet (1999) 4.16
Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest (2003) 4.06
Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg (2003) 3.13
FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J (2000) 2.25
Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc Natl Acad Sci U S A (2000) 2.23
PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci U S A (2000) 2.17
An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer. Health Aff (Millwood) (2012) 2.16
Effects of perfusion on radiofrequency ablation in swine kidneys. Radiology (2004) 2.07
Disparities in colorectal cancer screening rates among Asian Americans and non-Latino whites. Cancer (2005) 2.06
Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health (2000) 1.99
Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol (2001) 1.89
Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort. J Clin Oncol (2009) 1.89
Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol (2001) 1.82
Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One (2012) 1.80
Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma. Am J Pathol (2001) 1.69
Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2007) 1.66
Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet (2000) 1.64
Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases. Virchows Arch (2006) 1.57
Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? Am J Public Health (2003) 1.57
Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev (2001) 1.54
A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet (2000) 1.51
Obesity and renal cell cancer--a quantitative review. Br J Cancer (2001) 1.51
Development of Alive! (A Lifestyle Intervention Via Email), and its effect on health-related quality of life, presenteeism, and other behavioral outcomes: randomized controlled trial. J Med Internet Res (2008) 1.47
Characterization of osteolytic, osteoblastic, and mixed lesions in a prostate cancer mouse model using 18F-FDG and 18F-fluoride PET/CT. J Nucl Med (2008) 1.43
Diagnosis of hepatocellular carcinoma. HPB (Oxford) (2005) 1.43
The long terminal repeat of Jaagsiekte sheep retrovirus is preferentially active in differentiated epithelial cells of the lungs. J Virol (2000) 1.41
Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness. Eur Radiol (2003) 1.38
Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am J Pathol (2002) 1.36
Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg (2001) 1.36
PGDB: a curated and integrated database of genes related to the prostate. Nucleic Acids Res (2003) 1.35
Lessons from border cell migration in the Drosophila ovary: A role for myosin VI in dissemination of human ovarian cancer. Proc Natl Acad Sci U S A (2004) 1.34
Colorectal cancer screening among African Americans: the importance of physician recommendation. J Natl Med Assoc (2003) 1.34
Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory. Antioxid Redox Signal (2010) 1.33
Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg (2007) 1.32
Pathobiology of brain metastases. J Clin Pathol (2005) 1.29
FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A. Oncogene (2009) 1.29
Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol (2003) 1.29
Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array. Br J Cancer (2007) 1.26
Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases. BMC Cancer (2008) 1.26
Infrared micro-spectral imaging: distinction of tissue types in axillary lymph node histology. BMC Clin Pathol (2008) 1.26
Colorectal cancer risk perceptions and screening intentions in a minority population. J Natl Med Assoc (2000) 1.26
Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells. Am J Pathol (2000) 1.26
Transcriptional regulation of BRCA1 expression by a metabolic switch. Nat Struct Mol Biol (2010) 1.25
Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines. Br J Cancer (2002) 1.24
Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br J Cancer (2004) 1.23
MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLoS One (2011) 1.23
Morphological effects of chemotherapy on ovarian carcinoma. J Clin Pathol (2002) 1.22
Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. Br J Cancer (2005) 1.21
Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol (2010) 1.20
Decision analysis for the cost-effective management of recurrent colorectal cancer. Ann Surg (2001) 1.19
Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. Virchows Arch (2012) 1.18
HER 2/neu protein expression in colorectal cancer. BMC Cancer (2006) 1.18
Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells. Mol Cancer (2005) 1.18
MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate. Br J Cancer (2004) 1.17
BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat (2008) 1.16
Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance. Mol Med (2008) 1.16
Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet (2010) 1.15
MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells. Br J Cancer (2007) 1.14
Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc Natl Acad Sci U S A (2002) 1.14
Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites. Neoplasia (2002) 1.13
Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET. Oncogenesis (2013) 1.13
Costs and cost-effectiveness of a church-based intervention to promote mammography screening. Health Serv Res (2000) 1.13
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck. Br J Cancer (2001) 1.11
Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features. Am J Pathol (2001) 1.11
Which is the best method of sterilization of tumour bone for reimplantation? A biomechanical and histopathological study. Biomed Eng Online (2010) 1.11
Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line. BMC Cancer (2006) 1.11
Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice. Am J Pathol (2006) 1.11
The stress protein BAG3 stabilizes Mcl-1 protein and promotes survival of cancer cells and resistance to antagonist ABT-737. J Biol Chem (2013) 1.11
Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus. Surg Endosc (2002) 1.09
Requirement of an integrated immune response for successful neuroattenuated HSV-1 therapy in an intracranial metastatic melanoma model. Mol Ther (2003) 1.09
Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer. Breast Cancer Res (2000) 1.09
Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr (2003) 1.08
STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines. Br J Cancer (2006) 1.08
Progression to androgen-independent LNCaP human prostate tumors: cellular and molecular alterations. Int J Cancer (2004) 1.07
Cervical cancer prevention--cervical screening: science in evolution. Obstet Gynecol Clin North Am (2007) 1.07
Actual role of radiofrequency ablation of liver metastases. Eur Radiol (2007) 1.07
Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Cancer Lett (2009) 1.07
RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis. Mol Cancer (2007) 1.06
Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines. Int J Cancer (2009) 1.05
Metallothionein isoform 3 as a potential biomarker for human bladder cancer. Environ Health Perspect (2000) 1.05
B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.04
Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1). Mol Med (2012) 1.04
Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics. J Biol Chem (2012) 1.04
The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells. Mol Cancer Ther (2006) 1.04
Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg (2006) 1.03
Metastatic breast cancer cells suppress osteoblast adhesion and differentiation. Clin Exp Metastasis (2004) 1.03
Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins. Br J Cancer (2000) 1.03
Impaired transforming growth factor beta signalling in Barrett's carcinogenesis due to frequent SMAD4 inactivation. Gut (2005) 1.03
Results of long-term follow-up after curative resection of Dukes A colorectal cancer. World J Surg (2002) 1.02
Racial differences in the androgen/androgen receptor pathway in prostate cancer. J Natl Med Assoc (1999) 1.00
Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression. Acta Pharmacol Sin (2009) 1.00
A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol (2002) 1.00
Overexpression of T lymphoma invasion and metastasis 1 predict renal cell carcinoma metastasis and overall patient survival. J Cancer Res Clin Oncol (2010) 1.00
WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Neoplasia (2003) 0.99
Risk factors for postoperative recurrence in patients with pathologically T1 colorectal cancer. World J Surg (2012) 0.99
Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107. Proc Natl Acad Sci U S A (2003) 0.98
Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1. Cancer Res (2007) 0.98
Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia (2002) 0.98
Cancer statistics, 2000. CA Cancer J Clin (2000) 12.32
Cancer statistics, 2001. CA Cancer J Clin (2001) 11.73
Cancer statistics, 1996. CA Cancer J Clin (1996) 6.85
Cancer statistics, 1998. CA Cancer J Clin (1998) 6.26
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Cancer statistics, 1997. CA Cancer J Clin (1997) 5.22
The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer (2000) 4.89
Cancer statistics, 1995. CA Cancer J Clin (1995) 4.73
Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst (2001) 4.26
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. Clin Cancer Res (1999) 3.24
Oral contraceptives and breast cancer in young women. Lancet (1985) 2.36
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Comparison of mammography and Pap test use from the 1987 and 1992 National Health Interview Surveys: are we closing the gaps? Am J Prev Med (1996) 2.28
Cancer statistics by race and ethnicity. CA Cancer J Clin (1998) 2.18
Family history and the risk of breast cancer. JAMA (1985) 1.87
Multiple myeloma and the anion gap. N Engl J Med (1975) 1.72
Lung cancer after radiation therapy for breast cancer. Cancer (1993) 1.68
The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol (1989) 1.68
Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer (1994) 1.67
The relationship between body mass and breast cancer among women enrolled in the Cancer and Steroid Hormone Study. J Clin Epidemiol (1991) 1.67
Rationale, design and methods of the HEALTHY study physical education intervention component. Int J Obes (Lond) (2009) 1.61
Dietary risk factors for the incidence and recurrence of colorectal adenomatous polyps. A case-control study. Ann Intern Med (1993) 1.58
Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group. Cancer (1992) 1.51
An internally-standardized assay for amphotericin B in tissues and plasma. J Chromatogr (1983) 1.46
Trends in hospitalizations for abnormal uterine bleeding in the United States: 1980-1992. J Womens Health (1997) 1.45
Genetic testing for cancer risk: how to reconcile the conflicts. JAMA (1998) 1.42
Differences in histology between first and second primary lung cancer. Cancer Epidemiol Biomarkers Prev (1993) 1.41
Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid. J Nucl Med (1988) 1.41
Hemodynamic effects of oral smokeless tobacco in dogs and young adults. Prev Med (1984) 1.31
Sun exposure and sun-protection behaviors and attitudes among U.S. youth, 11 to 18 years of age. Prev Med (2001) 1.31
Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States. Obstet Gynecol (1995) 1.30
The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA (1987) 1.29
Epidemiological research at the American Cancer Society. Cancer Epidemiol Biomarkers Prev (2000) 1.23
The diagnosis of ovarian cancer by pathologists: how often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists? Am J Obstet Gynecol (1991) 1.22
Chronic interstitial nephritis: etiologic factors. Ann Intern Med (1975) 1.21
The mortality risk associated with hysterectomy. Am J Obstet Gynecol (1985) 1.21
The practice nurse: is history repeating itself? Br Med J (Clin Res Ed) (1986) 1.20
Research on infertility: definition makes a difference. The Cancer and Steroid Hormone Study Group. Am J Epidemiol (1989) 1.19
Effects of cimetidine on carbamazepine auto- and hetero-induction in man. Br J Clin Pharmacol (1984) 1.19
Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med (1979) 1.12
Family history and risk of fatal prostate cancer. Epidemiology (1997) 1.12
Psychosocial measurement: implications for the study of preterm delivery in black women. Am J Prev Med (1994) 1.12
Cancer statistics for African Americans, 1996. CA Cancer J Clin (1996) 1.11
Risk factors for synchronous primary endometrial and ovarian cancers. Ann Epidemiol (2001) 1.10
Tubal ligation and fatal ovarian cancer in a large prospective cohort study. Am J Epidemiol (1997) 1.08
Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab (1995) 1.08
Hysterectomy, tubal sterilization, and the risk of breast cancer. Am J Epidemiol (1988) 1.07
The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour. Br J Cancer (1991) 1.07
Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients. Br J Cancer (2003) 1.05
A review of the relationship between coffee consumption and coronary heart disease. J Community Health (1990) 1.04
Characterization of dacC, which encodes a new low-molecular-weight penicillin-binding protein in Bacillus subtilis. J Bacteriol (1998) 1.03
Nephrotoxicity of newer cephalosporins and aminoglycosides alone and in combination in a rat model. J Antimicrob Chemother (1978) 1.03
Physical activity, functional limitations, and the risk of fall-related fractures in community-dwelling elderly. Ann Epidemiol (1997) 1.02
Diethylstilbestrol and risk of fatal breast cancer in a prospective cohort of US women. Am J Epidemiol (1996) 1.01
Agreement of self-reported ovarian number following gynecologic surgery with medical record reports. J Clin Epidemiol (1990) 1.00
Cancer prevention in the dental practice: oral cancer screening and tobacco cessation advice. J Public Health Dent (1996) 1.00
Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis. Gut (1986) 0.99
Characterization of ywhE, which encodes a putative high-molecular-weight class A penicillin-binding protein in Bacillus subtilis. Gene (2000) 0.96
Home environmental hazards and the risk of fall injury events among community-dwelling older persons. Study to Assess Falls Among the Elderly (SAFE) Group. J Am Geriatr Soc (1998) 0.96
Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol (1991) 0.96
A novel method for fast imaging of brain function, non-invasively, with light. Opt Express (1998) 0.95
Cyclic adenosine-3',5'-monophosphate stimulates islet B cell replication in neonatal rat pancreatic monolayer cultures. J Clin Invest (1980) 0.95
A tumour spheroid model for antibody-targeted therapy of micrometastases. Br J Cancer (1988) 0.95
Nitric oxide production is inhibited in trauma patients. J Trauma (1993) 0.92
Alcohol consumption and risk of breast cancer. Lancet (1983) 0.90
The distribution of alternative agents for targeted radiotherapy within human neuroblastoma spheroids. Br J Cancer (1991) 0.90
Alcohol consumption increases the risk of fatal breast cancer (United States). Cancer Causes Control (2001) 0.90
Categorization in accident departments: 'good' patients, 'bad' patients and 'children'. Sociol Health Illn (1983) 0.90
Severe reaction to diphosphonate: implications for treatment of Paget's disease. BMJ (1988) 0.89
Inhibition of adipose conversion in 3T3-L2 cells by retinoic acid. J Supramol Struct (1980) 0.89
Chronic medical conditions and risk of fall injury events at home in older adults. J Am Geriatr Soc (1997) 0.88
Cigarette smoking and the risk of breast cancer. Am J Epidemiol (1990) 0.86
Poor survival of treatment-related acute nonlymphocytic leukemia. JAMA (1990) 0.85
Alcohol consumption and the risk of breast cancer. Am J Epidemiol (1989) 0.85
Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies. Am J Obstet Gynecol (1990) 0.85
Bone mineral content in idiopathic calcium nephrolithiasis. Miner Electrolyte Metab (1985) 0.85
Systemic lupus erythematosus and reproductive function: a case-control study. Am J Obstet Gynecol (1985) 0.84
Microwave hyperthermia for choroidal melanoma in rabbits. Invest Ophthalmol Vis Sci (1990) 0.84
Analgesic abuse and renal disease. Annu Rev Med (1975) 0.83
A test of the auricular surface aging technique. J Forensic Sci (1991) 0.82
Family history of breast cancer as a predictor for fatal prostate cancer. Epidemiology (1998) 0.82
Uptake of gentamicin by separated, viable renal tubules from rabbits. J Infect Dis (1980) 0.82
Liposomal distribution in malignant glioma: possibilities for therapy. Nucl Med Commun (1997) 0.82
Training responses of plasma beta-endorphin, adrenocorticotropin, and cortisol. Med Sci Sports Exerc (1989) 0.81
Tubal sterilization and risk of breast cancer mortality in US women. Cancer Causes Control (2001) 0.81
Colorectal cancer: differences between community and geographically distant patients seen at an urban medical center. Dis Colon Rectum (1991) 0.80
A comparison of the clinical characteristics of first and second primary head and neck cancers. A population-based study. Cancer (1991) 0.80
Cervical cancer incidence and screening: status report on women in the United States. Cancer Pract (1996) 0.79
Cigarette smoking and other behavioral risk factors for recurrence of colorectal adenomatous polyps (New York City, NY, USA). Cancer Causes Control (1994) 0.79
Female sterilizations in the United States, 1987. Fam Plann Perspect (1989) 0.79
Differential penetration of targeting agents into multicellular spheroids derived from human neuroblastoma. Prog Clin Biol Res (1991) 0.79
Oral contraceptives and breast cancer in young women. Lancet (1986) 0.78
Tumor spheroid model for the biologically targeted radiotherapy of neuroblastoma micrometastases. Cancer Res (1990) 0.78
Spontaneous abortion and risk of fatal breast cancer in a prospective cohort of United States women. Cancer Causes Control (1995) 0.78